Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
167 hedge funds and large institutions have $272M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 23 closing their positions.
170% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $730K
48% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 46
0% more funds holding
Funds holding: 167 → 167 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
5% less capital invested
Capital invested by funds: $287M → $272M (-$14.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$12.8M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.89M |
| 3 |
Citigroup
New York
|
+$3.14M |
| 4 |
BlackRock
New York
|
+$2.33M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$6.63M |
| 2 |
Millennium Management
New York
|
-$4.4M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.2M |
| 4 |
Renaissance Technologies
New York
|
-$3.07M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$2.71M |
SCMP Hedge Fund Activity: Q2 2017 in Review
167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2017, worth a combined $272M — down 5.2% from $287M a quarter earlier.
Fund positioning in SCMP was balanced in Q2 2017: 23 funds opened new positions, 23 closed out, 68 added to existing stakes and 46 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $12.8M. The largest seller was Redwood Investments, exiting entirely with an estimated $6.63M sold.
- 167 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $272M of Sucampo Pharmaceuticals, Inc. stock for Q2 2017, down 5.2% quarter-over-quarter.
- 23 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2017 and 23 closed out, a net change of 0 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q2 2017 was NEA Management Company, an estimated $12.8M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2017 was Redwood Investments, an estimated $6.63M sold.
Based on aggregated 13F filings for Q2 2017.